Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants
出版年份 2023 全文链接
标题
Cognitive Effects of Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease with GBA1 Pathogenic Variants
作者
关键词
-
出版物
MOVEMENT DISORDERS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-02
DOI
10.1002/mds.29647
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Genetic Testing in Parkinson's Disease
- (2023) Gian Pal et al. MOVEMENT DISORDERS
- Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers
- (2022) Gian Pal et al. ANNALS OF NEUROLOGY
- GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study
- (2022) Aleksandra A. Szwedo et al. MOVEMENT DISORDERS
- Pronounced Orthostatic Hypotension in GBA-Related Parkinson’s Disease
- (2022) Tatiana Usnich et al. Journal of Parkinsons Disease
- Cognitive Effects of Deep Brain Stimulation in GBA ‐Related Parkinson Disease
- (2022) Caroline Weill et al. ANNALS OF NEUROLOGY
- Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease
- (2022) Linn Oftedal et al. NEUROLOGY
- Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study
- (2022) Daniel Weiss et al. PARKINSONISM & RELATED DISORDERS
- Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
- (2022) Michael J Soileau et al. LANCET NEUROLOGY
- The pharmacokinetics of continuous subcutaneous levodopa/carbidopa infusion: Findings from the ND0612 clinical development program
- (2022) Peter A. LeWitt et al. Frontiers in Neurology
- Genotype-driven therapeutic developments in Parkinson’s disease
- (2021) Jannik Prasuhn et al. MOLECULAR MEDICINE
- Accelerating Medicines Partnership: Parkinson's Disease. Genetic Resource
- (2021) Hirotaka Iwaki et al. MOVEMENT DISORDERS
- Penetrance of Glucocerebrosidase ( GBA ) Mutations in Parkinson’s Disease: a Kin Cohort Study
- (2020) Roberta Balestrino et al. MOVEMENT DISORDERS
- Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations
- (2020) Graziella Mangone et al. PARKINSONISM & RELATED DISORDERS
- The SPID-GBA study
- (2020) Letizia Straniero et al. Neurology-Genetics
- Quality of life predicts outcome of deep brain stimulation in early Parkinson disease
- (2019) W.M. Michael Schuepbach et al. NEUROLOGY
- Long-term outcomes of deep brain stimulation in Parkinson disease
- (2019) Patricia Limousin et al. Nature Reviews Neurology
- Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson’s disease
- (2019) Doreen Gruber et al. JOURNAL OF NEURAL TRANSMISSION
- Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary
- (2018) Anand Rughani et al. NEUROSURGERY
- GBA-Associated Parkinson’s Disease: Progression in a Deep Brain Stimulation Cohort
- (2017) Vanessa Lythe et al. Journal of Parkinsons Disease
- Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
- (2016) Ganqiang Liu et al. ANNALS OF NEUROLOGY
- Survival and dementia inGBA-associated Parkinson's disease: The mutation matters
- (2016) Roberto Cilia et al. ANNALS OF NEUROLOGY
- Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease
- (2016) Elena Lezcano et al. JOURNAL OF NEUROLOGY
- Association ofGBAMutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease
- (2016) Marie Y. Davis et al. JAMA Neurology
- Glucocerebrosidase activity in Parkinson’s disease with and withoutGBAmutations
- (2015) Roy N. Alcalay et al. BRAIN
- Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial
- (2015) Fabian J. David et al. MOVEMENT DISORDERS
- Impact of glucocerebrosidase mutations on motor and nonmotor complications in Parkinson's disease
- (2015) Tomoko Oeda et al. NEUROBIOLOGY OF AGING
- Surviving 10 years with deep brain stimulation for Parkinson's disease - a follow-up of 79 patients
- (2014) M. Bang Henriksen et al. EUROPEAN JOURNAL OF NEUROLOGY
- Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach
- (2014) Iciar Aviles-Olmos et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Mood and behavioural effects of subthalamic stimulation in Parkinson's disease
- (2014) Anna Castrioto et al. LANCET NEUROLOGY
- Glucocerebrosidase mutations in primary parkinsonism
- (2014) Rosanna Asselta et al. PARKINSONISM & RELATED DISORDERS
- Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study
- (2013) C Warren Olanow et al. LANCET NEUROLOGY
- Genotype and phenotype in Parkinson's disease: Lessons in heterogeneity from deep brain stimulation
- (2013) Aikaterina Angeli et al. MOVEMENT DISORDERS
- Neurostimulation for Parkinson's Disease with Early Motor Complications
- (2013) W.M.M. Schuepbach et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-specific Parkinson disease risk in GBA mutation carriers: information for genetic counseling
- (2012) Huma Q. Rana et al. GENETICS IN MEDICINE
- The link between the GBA gene and parkinsonism
- (2012) Ellen Sidransky et al. LANCET NEUROLOGY
- Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial
- (2012) Vincent JJ Odekerken et al. LANCET NEUROLOGY
- Rate of cognitive decline in premotor Parkinson's disease: A prospective study (NEDICES)
- (2012) Álvaro Sánchez-Ferro et al. MOVEMENT DISORDERS
- Randomized trial of deep brain stimulation for Parkinson disease: Thirty-six-month outcomes
- (2012) F. M. Weaver et al. NEUROLOGY
- Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers
- (2012) M. Anheim et al. NEUROLOGY
- The Parkinson Progression Marker Initiative (PPMI)
- (2011) Kenneth Marek et al. PROGRESS IN NEUROBIOLOGY
- Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants
- (2010) A. Fasano et al. BRAIN
- Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
- (2009) Juliane Neumann et al. BRAIN
- Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's Disease
- (2009) H. M. M. Smeding et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease
- (2009) Jens Volkmann et al. MOVEMENT DISORDERS
- Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study
- (2008) Karsten Witt et al. LANCET NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now